What is GSK plc (GSK)?

GSK plc (GSK) is a stock in the Healthcare sector, Drug Manufacturers - General industry. View full analysis on Stocks360.

What is the current price of GSK?

The current price of GSK is $50.94. Prices are updated in real time on Stocks360.

What is GSK's price-to-earnings (PE) ratio?

GSK's trailing twelve-month PE ratio is 15.05, based on current price and earnings per share data available on Stocks360.

What is GSK's market capitalization?

GSK's market capitalization is $102,340,979,849.00, placing it in the large-cap tier.

Does GSK pay a dividend?

Yes. GSK has a trailing twelve-month dividend yield of 0.04%. Dividend data is sourced from financial market providers and displayed on Stocks360.

GSK plc (GSK)

Stock analysis · NYSE · Healthcare · Drug Manufacturers - General

$50.94

Market Cap

$102.34B

PE (TTM)

15.05

EPS (TTM)

N/A

Dividend Yield

3.77%

Beta

0.28

Day Range

$50.64 – $51.25

52-wk Range

$42.89 – $61.70

Avg Volume

N/A

Volume

4.70M

GSK plc (GSK) is a publicly traded company in the Healthcare sector. Latest price: $50.94. Market cap $102.34B. Trailing PE 15.05. Dividend yield 3.77%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $43.70 2026-10-27 · $50.94 (+16.57%)

Earnings

Most Recent

Oct 28, 2026

EPS $1.47 vs est. $1.33

Beat by $0.14

Next Earnings

Feb 3, 2027

EPS estimate $0.78

Proprietary Signals

Signal snapshot temporarily unavailable.

About GSK plc

GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnership…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	15.05×
P/S (TTM)	2.18×
P/B	4.11×
PEG	0.35×
P/FCF (TTM)	12.57×
EV / EBITDA	8.18×
EV / Sales	2.63×
Earnings Yield	6.65%
Free Cash Flow Yield	7.96%
Dividend Yield	3.77%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$87.48B
Revenue (TTM)	$33.20B
Net Income (TTM)	$4.81B
Free Cash Flow (TTM)	$6.40B
Net Debt	$15.13B
Working Capital	-$3.98B
Gross Margin	73.29%
Operating Margin	24.12%
Net Margin	14.52%
Return on Equity	28.35%
Return on Invested Capital	16.04%